**riel "call me Fib" Hewitt swoops on Cryosite

Investment opportunist, **riel Hewitt, is swooping on the Cryosite share register.

On August 6, Hewitt - aka @Fibonarchery - stitched the single biggest CTE share deal of the year.

He astutely bought 234,112 units at 4c, 20% below the previous close. Seller would appear to National Nominees.

The deal propelled Hewitt into CTE's Top 20 shareholder list.

Soon after the purchase, an anonymous buyer placed a single low-ball order for 750,000 shares at 3.1c.

The buyer then hoisted the bid to 4c. At the close of trade yesterday the buyer was holding firm at that level.

Who is this buyer?  I suspect it's **riel Hewitt. Why?  Because in recent times there are precedents for him - and his Perth-based Bull Equities affiliate - taking a modest maiden position and then building to at least 5%.  

It's not the first time @Fibonarchery has taken an interest in CTE. He regularly posted on the stock when he was one of the most followed operators on Hot Copper.

The last time he posted was on December 30, 2013. The share price was then 47c.  It would seem he sold at or near the top.

Now, six years later, Hewitt may be thinking that CTE can assail the previous record.

Hewitt - a bitcoin trading pioneer - would be aware that Cryosite has ~$5m cash at bank.

The group is debtless and claims to be "fundamentally breaking even", having put its ACCC legal woes behind.

But Melbourne-based Hewitt would also be aware that Cryosite is a prime takeover prospect.

Ambitious offshore operators such as Atlanta's $UPS/United Parcel Service are circling Australia's $1b a year clinical trials industry and its cold storage logistics infrastructure.

They know Cryosite commands a central position.

Meanwhile, **riel Hewitt might be asking his question: What will CHAMP Private Equity do with its strategic, 19.7% CTE stake held in the name of Cell Care Australia?